{
  "items": [
    {
      "date": "2026-01-08",
      "title": "Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-celebrates-innovation-in-cancer-research-with-2025-dr-paul-janssen-award",
      "already_processed": true
    },
    {
      "date": "2026-01-07",
      "title": "Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration",
      "already_processed": true
    },
    {
      "date": "2026-01-06",
      "title": "Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-application-to-the-european-medicines-agency-for-tecvayli-teclistamab-in-combination-with-darzalex-daratumumab-subcutaneous-formulation-for-patients-with-relapsed-refractory-multiple-myeloma",
      "already_processed": true
    },
    {
      "date": "2026-01-06",
      "title": "Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-unveils-new-data-showing-nipocalimab-is-the-first-and-only-investigational-fcrn-blocker-with-potential-to-reduce-systemic-lupus-erythematosus-sle-activity-in-a-phase-2-study",
      "already_processed": true
    },
    {
      "date": "2026-01-02",
      "title": "Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2026",
      "already_processed": true
    },
    {
      "date": "2025-12-29",
      "title": "Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-halda-therapeutics-and-its-novel-platform-to-revolutionize-cancer-treatment-and-enable-next-generation-oral-therapies",
      "already_processed": true
    },
    {
      "date": "2025-12-26",
      "title": "Johnson & Johnson Statement on the Phase 2b DUPLEX-AD Study",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-statement-on-the-phase-2b-duplex-ad-study",
      "already_processed": true
    },
    {
      "date": "2025-12-22",
      "title": "European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor",
      "url": "https://www.jnj.com/media-center/press-releases/european-commission-approves-tremfya-guselkumab-for-the-treatment-of-children-with-plaque-psoriasis-marking-the-first-paediatric-indication-for-an-il-23-inhibitor",
      "already_processed": true
    },
    {
      "date": "2025-12-19",
      "title": "Johnson & Johnson Backs HRS Registry to Advance Real-World Evidence in PFA",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-backs-hrs-registry-to-advance-real-world-evidence-in-pfa",
      "already_processed": true
    },
    {
      "date": "2025-12-18",
      "title": "Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma",
      "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-receives-fda-approval-for-trufill-n-bca-liquid-embolic-system-for-the-treatment-of-symptomatic-chronic-subdural-hematoma",
      "already_processed": true
    }
  ]
}